{"id":679,"date":"2012-02-22T00:50:45","date_gmt":"2012-02-22T00:50:45","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=679"},"modified":"2016-05-17T20:42:37","modified_gmt":"2016-05-17T20:42:37","slug":"wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy","status":"publish","type":"post","link":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/","title":{"rendered":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy?"},"content":{"rendered":"<p><strong>Today\u2019s testimony focused on part 4 of Bill C-10, which would amend the Youth Criminal Justice Act. <\/strong>Specifically, these amendments would allow a judge to lift the publication ban on cases involving defendants as young as 12 years old, introduce dissuasion and deterrence as principals of Canadian youth justice, and make it easier to incarcerate youth convicted of violent crimes.<\/p>\n<p>The committee heard from a number of lawyers and children\u2019s advocates, including <a href=\"http:\/\/www.unicef.ca\/sites\/default\/files\/imce_uploads\/TAKE%20ACTION\/ADVOCATE\/DOCS\/UNICEF%20Canada%20submission%20-%20Bill%20C-4%20submission.pdf\" target=\"_blank\">Marvin Bernstein<\/a> of UNICEF Canada, <a href=\"http:\/\/www.rcybc.ca\/Images\/Who%20We%20Are\/Mary%20Ellen%20Bio%20Oct%202011.pdf\" target=\"_blank\">Mary-Ellen Turpel-Lafond<\/a>, President, and <a href=\"http:\/\/www2.cdpdj.qc.ca\/en\/Commission\/members\/Pages\/godin_EN.html\" target=\"_blank\">Sylvie Godin<\/a>, Vice-President of the Canadian Council of Child and Youth Advocates, and <a href=\"http:\/\/www.glennsigurdson.com\/about\/barry-stuart\/\" target=\"_blank\">Judge Barry Stuart<\/a>, former Chief Justice of the Yukon.<\/p>\n<blockquote><p>These witnesses unanimously protested nearly all of the proposed amendments to the Youth Criminal Justice Act. They claimed that allowing judges to lift publication bans would have disastrous long-term consequences for young people.<\/p><\/blockquote>\n<p>They also argued that, in the case of young offenders, a violent crime can mean throwing a snowball, throwing water on someone, or threatening a classmate. Bernstein, Turpel-Lafond and Godin also told the committee that, in their opinion, the proposed amendments were in contravention with the UN Convention on the Rights of the Child, to which Canada is a signatory.<\/p>\n<p>Judge Barry Stuart, a pioneer in restorative justice, had <a href=\"http:\/\/www.cbc.ca\/thecurrent\/interviews\/2012\/01\/11\/judge-barry-stuart-on-bill-c-10\/\" target=\"_blank\">particularly severe warnings<\/a> for the committee, claiming that if they went down this road, and further criminalized young people, that they would never attain the goals of improving victims\u2019 rights and engaging communities in offender rehabilitation. Rather, the \u201ctail-end\u201d of the criminal justice system would suck up all resources that could have far greater impact on justice and public safety if spent elsewhere.<\/p>\n<p>Many Conservative senators repeated standard responses to the testimony of these witnesses. Rather than asking questions, their cross-examination seemed more an attempt to discredit their testimony.\u00a0This behaviour has seemed most often on display when the committee is hearing from academic experts and legal professionals, whereas it changes to a more conciliatory tone in the presence of law enforcement officials.<\/p>\n<blockquote><p>In response to the very real problems outlined in regards to Bill C-10, Senator Wallace once again repeated his favourite line: \u201cBut when Ministers Toews and Nicholson appeared before this committee, they assured us that the bill will only target violent, repeat offenders, organized criminals, and child abusers.\u201d<\/p><\/blockquote>\n<p>Senator Wallace seems to believe that simply repeating this mantra will make it true, despite the mountains of evidence given by representatives of children\u2019s advocacy groups, the Canadian Bar Association, the Assembly of First Nations, as well as independent academics and many others. Unfortunately, the CDPC was not permitted to add its voice to this overwhelming chorus.<\/p>\n<p>The comportment of these Conservative Senators\u2014Boisvenu, Lang, Frum, Dagenais, and Wallace\u2014seems to indicate that they don\u2019t understand the fundamental purpose of their own position: to give a sober second thought to proposed legislation one step removed from the dictates of electoral politics. Indeed, during hearings today Senator Lang went so far as to claim that \u201cone might argue the nuances or the details, but it\u2019s the spirit of the law that matters.\u201d Perhaps no one told Senator Lang that the nuances and the details of the law are <em>precisely<\/em> what a senate committee is meant to discuss.<\/p>\n<blockquote><p>Perhaps this disdain for evidence is what prompted Judge Barry Stuart\u2019s remark that the Senate, \u201cprobably spends more time weighing evidence on which military aircraft to purchase than on weighing evidence on what is best for our youth.\u201d<\/p><\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Today\u2019s testimony focused on part 4 of Bill C-10, which would amend the Youth Criminal Justice Act. Specifically, these amendments would allow a judge to lift the publication ban on cases involving defendants as young as 12 years old, introduce dissuasion and deterrence as principals of Canadian youth justice, and make it easier to incarcerate [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2825,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1,20,17,29,27],"tags":[],"class_list":["post-679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all","category-drug-law-reform","category-harm-reduction","category-regulation","category-supervised-consumption-services"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Today\u2019s testimony focused on part 4 of Bill C-10, which would amend the Youth Criminal Justice Act. Specifically, these amendments would allow a judge to lift the publication ban on cases involving defendants as young as 12 years old, introduce dissuasion and deterrence as principals of Canadian youth justice, and make it easier to incarcerate [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2012-02-22T00:50:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-05-17T20:42:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"415\" \/>\n\t<meta property=\"og:image:height\" content=\"415\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy?\",\"datePublished\":\"2012-02-22T00:50:45+00:00\",\"dateModified\":\"2016-05-17T20:42:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/\"},\"wordCount\":587,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDPC_SenatePolicy_Blog_415x415px-S.jpg\",\"articleSection\":[\"All\",\"Drug Law Reform\",\"Harm Reduction\",\"Regulation\",\"Supervised Consumption Services\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/\",\"name\":\"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDPC_SenatePolicy_Blog_415x415px-S.jpg\",\"datePublished\":\"2012-02-22T00:50:45+00:00\",\"dateModified\":\"2016-05-17T20:42:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDPC_SenatePolicy_Blog_415x415px-S.jpg\",\"contentUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/02\\\/CDPC_SenatePolicy_Blog_415x415px-S.jpg\",\"width\":415,\"height\":415},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/","og_locale":"fr_FR","og_type":"article","og_title":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition","og_description":"Today\u2019s testimony focused on part 4 of Bill C-10, which would amend the Youth Criminal Justice Act. Specifically, these amendments would allow a judge to lift the publication ban on cases involving defendants as young as 12 years old, introduce dissuasion and deterrence as principals of Canadian youth justice, and make it easier to incarcerate [&hellip;]","og_url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2012-02-22T00:50:45+00:00","article_modified_time":"2016-05-17T20:42:37+00:00","og_image":[{"width":415,"height":415,"url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#article","isPartOf":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/"},"author":{"name":"admin","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy?","datePublished":"2012-02-22T00:50:45+00:00","dateModified":"2016-05-17T20:42:37+00:00","mainEntityOfPage":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/"},"wordCount":587,"commentCount":0,"publisher":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#primaryimage"},"thumbnailUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg","articleSection":["All","Drug Law Reform","Harm Reduction","Regulation","Supervised Consumption Services"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/","name":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy? - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#primaryimage"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#primaryimage"},"thumbnailUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg","datePublished":"2012-02-22T00:50:45+00:00","dateModified":"2016-05-17T20:42:37+00:00","breadcrumb":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#primaryimage","url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg","contentUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2012\/02\/CDPC_SenatePolicy_Blog_415x415px-S.jpg","width":415,"height":415},{"@type":"BreadcrumbList","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wheres-the-beef-does-the-senate-have-an-aversion-to-evidence-based-policy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Where\u2019s the beef: does the Senate have an aversion to evidence-based policy?"}]},{"@type":"WebSite","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#website","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=679"}],"version-history":[{"count":0,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/679\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/2825"}],"wp:attachment":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}